# iHIVARNA Clinical Trial in HIV Infected Individuals

> **NCT02888756** · PHASE2 · TERMINATED · sponsor: **Rob Gruters** · enrollment: 33 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** iHIVARNA-01
- **BIOLOGICAL:** TriMix
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02888756
- **Lead sponsor:** Rob Gruters
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-04
- **Primary completion:** 2018-02-12
- **Final completion:** 2018-02-12
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Interim analysis did not show sufficient immunogenicity of IMP compared to placebo
- **Last updated:** 2019-12-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888756, "iHIVARNA Clinical Trial in HIV Infected Individuals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02888756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*